The University of Kansas Cancer Center-South — Kansas City, Missouri

The University of Kansas Cancer Center-South is a clinical research site located in Kansas City, Missouri, United States 64131.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

The University of Kansas Cancer Center-South has participated in 70 clinical trials with 39 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Kansas Cancer Center-South?

The University of Kansas Cancer Center-South has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Kansas Cancer Center-South conducted?

The University of Kansas Cancer Center-South has 70 clinical trials on record, with 39 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7.

Is The University of Kansas Cancer Center-South accredited by Crixeo Health?

The University of Kansas Cancer Center-South has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Kansas Cancer Center-South?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.